{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:45:25Z","timestamp":1789573525484,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1053\/j.semtcvs.2020.11.031","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:05:32Z","timestamp":1607000732000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiac Surgeons\u2019 Treatment Approaches for Infective Endocarditis Based on Patients\u2019 Substance Use History"],"prefix":"10.1053","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-8926","authenticated-orcid":false,"given":"Max Jordan","family":"Nguemeni Tiako","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed","family":"Mszar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Cornell","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Usman Bin","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnar","family":"Geirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2020.11.031_bib0001","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2014 United States , 2000 \u2013 2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0002","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.amjms.2016.10.002","article-title":"Endocarditis as a marker for new epidemics of injection drug use","volume":"352","author":"Keeshin","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0003","doi-asserted-by":"crossref","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3408-y","article-title":"Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: A retrospective cohort study","author":"Gray","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012465","article-title":"Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005\u20132014","volume":"9","author":"Mori","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.semtcvs.2018.07.016","article-title":"Recidivism is the leading cause of death among intravenous drug users who underwent cardiac surgery for infective endocarditis","volume":"31","author":"Nguemeni Tiako","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4558-2","article-title":"Long term surgical outcomes for infective endocarditis in people who inject drugs: A systematic review and meta-analysis","volume":"19","author":"Goodman-Meza","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0008","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jtcvs.2008.08.024","article-title":"Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis","volume":"137","author":"Fedoruk","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0009","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.genhosppsych.2019.01.008","article-title":"Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies","volume":"57","author":"Elbatarny","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0010","article-title":"Risk of reoperative valve surgery for endocarditis associated with drug use","author":"Mori","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0011","article-title":"Valvectomy versus replacement for the surgical treatment of tricuspid endocarditis","volume":"04","author":"Protos","year":"2018","journal-title":"Ann Thorac Surgery,"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0012","doi-asserted-by":"crossref","first-page":"610","DOI":"10.21037\/acs.2019.11.06","article-title":"Valvectomy versus replacement for the surgical treatment of infective tricuspid valve endocarditis: A systematic review and meta-analysis","volume":"8","author":"Luc","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0013","doi-asserted-by":"crossref","first-page":"630","DOI":"10.21037\/acs.2019.10.05","article-title":"Current AATS guidelines on surgical treatment of infective endocarditis","volume":"8","author":"Pettersson","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal","year":"2016","journal-title":"Am J Med"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0015","article-title":"Missed opportunities for treatment of opioid use disorder in the hospital setting: updating an outdated policy","author":"Berk","year":"2019","journal-title":"J Hosp Med"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","article-title":"Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study","volume":"102","author":"Bearnot","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0017","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.athoracsur.2014.02.010","article-title":"ETHICS IN CARDIOTHORACIC SURGERY when is enough enough? the dilemma of valve replacement in a recidivist intravenous drug user","volume":"97","author":"Hull","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0018","article-title":"How many times are enough? Infective endocarditis in drug users","volume":"0","author":"Mohammadi","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0019","unstructured":"Search for Surgeons | CTSNet. https:\/\/www.ctsnet.org\/surgeons. Accessed April 20, 2020"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw open"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hast.356","article-title":"Surgeons, intensivists, and discretion to refuse requested treatments","volume":"44","author":"Wicclair","year":"2014","journal-title":"Hastings Cent Rep"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0022","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0002-9149(75)90830-9","article-title":"Hemodynamic consequences of total removal of the tricuspid valve without prosthetic replacement","volume":"35","author":"Robin","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0023","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.athoracsur.2018.07.023","article-title":"Nuanced approach to surgical tricuspid valve endocarditis","volume":"107","author":"Nguemeni Tiako","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0024","article-title":"Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database","author":"Slaughter","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2017.07.015","article-title":"Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act","volume":"179","author":"Feder","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19066","article-title":"Association of Medicaid Expansion With Opioid Overdose Mortality in the United States","volume":"3","author":"Kravitz-Wirtz","year":"2020","journal-title":"JAMA Netw open"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0027","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1176\/appi.ps.201700315","article-title":"Buprenorphine use and spending for opioid use disorder treatment: Trends from 2003 to 2015","volume":"69","author":"Roberts","year":"2018","journal-title":"Psychiatr Serv"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0028","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1370\/afm.1595","article-title":"Barriers to primary care physicians prescribing buprenorphine","volume":"12","author":"Hutchinson","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0029","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1108\/S1057-6290(2012)0000014008","article-title":"Two Tiers of Biomedicalization: Methadone, Buprenorphine, and the Racial Politics of Addiction Treatment","volume":"14","author":"Hansen","year":"2012","journal-title":"Crit Perspect Addict"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0031","article-title":"Attitudes and approaches towards repeat valve surgery in recurrent injection drug use-associated infective endocarditis: a qualitative study","author":"Hayden","year":"2019","journal-title":"J Addict Med"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0032","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","article-title":"Injection drug use and outcomes after surgical intervention for infective endocarditis","volume":"100","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0033","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.athoracsur.2018.04.012","article-title":"Surgical management of tricuspid valve infective endocarditis: a systematic review and meta-analysis","volume":"106","author":"Yanagawa","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0034","doi-asserted-by":"crossref","first-page":"009","DOI":"10.1055\/s-0035-1551678","article-title":"Invited commentary: high risk cardiac surgery in intravenous drug-addicted patients: are there any limits for repetitive surgical treatment?","volume":"64","author":"Carrel","year":"2015","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2020.11.031_bib0035","article-title":"Commentary: When is repeated cardiac valve surgery justified during drug-associated infective endocarditis?","volume":"0","author":"Mennander","year":"2019","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067920304263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067920304263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:31:43Z","timestamp":1760905903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067920304263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["S1043067920304263"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2020.11.031","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Surgeons\u2019 Treatment Approaches for Infective Endocarditis Based on Patients\u2019 Substance Use History","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2020.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}